Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2013-03-01
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS
NCT03983681
Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community
NCT06608797
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
NCT07225868
A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
NCT06197685
Speed of Processing Training to Improve Cognition in Multiple Sclerosis
NCT02301260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
The experimental group will meet with a study team member twice a week for 4 weeks (8 sessions) and receive memory strategy training.
Stylistic Memory Enhancement
Control
The control group participants will meet with a study team member twice a week for 4 weeks (8 sessions) and receive control memory exercises.
Stylistic Memory Enhancement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stylistic Memory Enhancement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Major psychiatric disturbance (e.g. bipolar disorder, schizophrenia) and neurological history other than MS.
* Corticosteroid use within the last month prior to the participation.
* Less than 1 month post most recent exacerbation.
18 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kessler Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nancy Chiaravalloti
Director Neuropsychology and Neuroscience Research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-769-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.